Cargando…
The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study
BACKGROUND: Succinate dehydrogenase subunit B (SDHB) mutations are associated with aggressive pheochromocytoma (PHEO)/paraganglioma (PGL) behavior, often resulting in metastatic disease and fatal outcomes. These tumors are often larger, extra-adrenal, and contain lower catecholamine concentrations t...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223758/ https://www.ncbi.nlm.nih.gov/pubmed/25048685 http://dx.doi.org/10.1186/1471-2407-14-523 |
_version_ | 1782343256725520384 |
---|---|
author | Schovanek, Jan Martucci, Victoria Wesley, Robert Fojo, Tito del Rivero, Jaydira Huynh, Thanh Adams, Karen Kebebew, Electron Frysak, Zdenek Stratakis, Constantine A Pacak, Karel |
author_facet | Schovanek, Jan Martucci, Victoria Wesley, Robert Fojo, Tito del Rivero, Jaydira Huynh, Thanh Adams, Karen Kebebew, Electron Frysak, Zdenek Stratakis, Constantine A Pacak, Karel |
author_sort | Schovanek, Jan |
collection | PubMed |
description | BACKGROUND: Succinate dehydrogenase subunit B (SDHB) mutations are associated with aggressive pheochromocytoma (PHEO)/paraganglioma (PGL) behavior, often resulting in metastatic disease and fatal outcomes. These tumors are often larger, extra-adrenal, and contain lower catecholamine concentrations than other hereditary PHEOs/PGLs. This study evaluated the size and age at diagnosis of primary SDHB-related PHEOs/PGLs as independent predictors of their metastatic behavior and outcome (survival). METHODS: One hundred six patients with SDHB mutation-related PHEO/PGL were included in this retrospective study. The recorded largest diameters, locations, and patient ages at initial diagnosis of SDHB-related primary tumors were analyzed in the context of time to metastasis and patient survival. RESULTS: First, the development of metastatic disease in patients with primary tumors ≥4.5 cm was significantly earlier than in patients with smaller tumors (P = 0.003). Second, patients with primary tumors larger than 5.5 cm also had worse overall survival than patients with smaller tumors (P = 0.008). Third, age at initial diagnosis was found to be an independent predictor of patient survival (PHEOs: P = 0.041; PGLs: P < 0.001). Fourth, we did not observe a significant difference in survival based on the specific SDHB mutations or patient sex. CONCLUSION: Receiver operating characteristic curves established 4.5 cm as the best value to dichotomize the primary SDHB-related PHEO/PGL in order to evaluate the development of metastatic disease and 5.5 cm as the best value for survival prediction. Subsequently, the size of the primary tumor was found as an age-independent predictor of patient survival and metastases development in PGL. In both PHEO and PGL, age at diagnosis was found to be a size-independent predictor of patient survival. No significant difference was found in metastases development or patient survival between males and females or among specific SDHB mutations. This data further extends and supports previous recommendations that carriers with SDHB mutations must undergo early and regular evaluations to detect PHEO/PGL in order to achieve the best clinical outcome. |
format | Online Article Text |
id | pubmed-4223758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42237582014-11-08 The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study Schovanek, Jan Martucci, Victoria Wesley, Robert Fojo, Tito del Rivero, Jaydira Huynh, Thanh Adams, Karen Kebebew, Electron Frysak, Zdenek Stratakis, Constantine A Pacak, Karel BMC Cancer Research Article BACKGROUND: Succinate dehydrogenase subunit B (SDHB) mutations are associated with aggressive pheochromocytoma (PHEO)/paraganglioma (PGL) behavior, often resulting in metastatic disease and fatal outcomes. These tumors are often larger, extra-adrenal, and contain lower catecholamine concentrations than other hereditary PHEOs/PGLs. This study evaluated the size and age at diagnosis of primary SDHB-related PHEOs/PGLs as independent predictors of their metastatic behavior and outcome (survival). METHODS: One hundred six patients with SDHB mutation-related PHEO/PGL were included in this retrospective study. The recorded largest diameters, locations, and patient ages at initial diagnosis of SDHB-related primary tumors were analyzed in the context of time to metastasis and patient survival. RESULTS: First, the development of metastatic disease in patients with primary tumors ≥4.5 cm was significantly earlier than in patients with smaller tumors (P = 0.003). Second, patients with primary tumors larger than 5.5 cm also had worse overall survival than patients with smaller tumors (P = 0.008). Third, age at initial diagnosis was found to be an independent predictor of patient survival (PHEOs: P = 0.041; PGLs: P < 0.001). Fourth, we did not observe a significant difference in survival based on the specific SDHB mutations or patient sex. CONCLUSION: Receiver operating characteristic curves established 4.5 cm as the best value to dichotomize the primary SDHB-related PHEO/PGL in order to evaluate the development of metastatic disease and 5.5 cm as the best value for survival prediction. Subsequently, the size of the primary tumor was found as an age-independent predictor of patient survival and metastases development in PGL. In both PHEO and PGL, age at diagnosis was found to be a size-independent predictor of patient survival. No significant difference was found in metastases development or patient survival between males and females or among specific SDHB mutations. This data further extends and supports previous recommendations that carriers with SDHB mutations must undergo early and regular evaluations to detect PHEO/PGL in order to achieve the best clinical outcome. BioMed Central 2014-07-21 /pmc/articles/PMC4223758/ /pubmed/25048685 http://dx.doi.org/10.1186/1471-2407-14-523 Text en Copyright © 2014 Schovanek et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Schovanek, Jan Martucci, Victoria Wesley, Robert Fojo, Tito del Rivero, Jaydira Huynh, Thanh Adams, Karen Kebebew, Electron Frysak, Zdenek Stratakis, Constantine A Pacak, Karel The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study |
title | The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study |
title_full | The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study |
title_fullStr | The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study |
title_full_unstemmed | The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study |
title_short | The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study |
title_sort | size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with sdhb-related pheochromocytoma and paraganglioma: a retrospective cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223758/ https://www.ncbi.nlm.nih.gov/pubmed/25048685 http://dx.doi.org/10.1186/1471-2407-14-523 |
work_keys_str_mv | AT schovanekjan thesizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT martuccivictoria thesizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT wesleyrobert thesizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT fojotito thesizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT delriverojaydira thesizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT huynhthanh thesizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT adamskaren thesizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT kebebewelectron thesizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT frysakzdenek thesizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT stratakisconstantinea thesizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT pacakkarel thesizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT schovanekjan sizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT martuccivictoria sizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT wesleyrobert sizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT fojotito sizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT delriverojaydira sizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT huynhthanh sizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT adamskaren sizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT kebebewelectron sizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT frysakzdenek sizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT stratakisconstantinea sizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy AT pacakkarel sizeoftheprimarytumorandageatinitialdiagnosisareindependentpredictorsofthemetastaticbehaviorandsurvivalofpatientswithsdhbrelatedpheochromocytomaandparagangliomaaretrospectivecohortstudy |